Harvard Business Review

MARCH 2, 2011

Undertakings with $20 million price tags such as the post-merger integration of a giant pharmaceutical client and its equally humongous acquisition. Typically such purchasers are emerging from some sort of major corporate unpleasantness — a near bankruptcy, say, or having missed out, Nokia-like, on a ground-shaking technological shift.

Consultative 15

Consultative Strategy McKinsey Porter 15

Harvard Business Review

AUGUST 3, 2012

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. Nonetheless we counsel CEOs to mind the rhetoric.

Licensing 13

Licensing Depreciation Pharmaceuticals Budgeting 13

Harvard Business Review

DECEMBER 27, 2016

Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. The CEOs of both — John Noseworthy and Delos “Toby” Cosgrove — are highly skilled physicians. ” But this is changing.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. His friend, Dr. Shiping Liu, founder and CEO of Global Business Intelligence Consulting Co., Daniela Saltzman is an MBA student at HBS, class of 2011. Stay tuned. Eccles is a professor of management practice at HBS.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

SEPTEMBER 5, 2013

In 2011, Thierry Andretta, the CEO of French fashion company Lanvin, announced an initiative called "no email Wednesdays" because he thought people had stopped actually talking to each other. Marissa Mayer, Yahoo''s CEO, ended the company''s work-from-home policy to foster a more collaborative, innovative environment.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

NOVEMBER 20, 2015

Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail. Global supply chains can cut across many “cultures”: national, industry, technology, market segment, and more.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

MAY 10, 2013

The next few product launches were not nearly as successful and Ed Zander , a CEO who came in during the successful period, was unable to come up with any more hits. Moreover, firms are often investing in venture capital-type organizations with the hope of striking it lucky with a new technology or offer.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8